TAHO Pharmaceuticals reports progress on Japan-marketed Ondansetron ODF
AI Summary- TAHO Pharmaceuticals reported progress on its Ondansetron ODF product.
- Ondansetron ODF is already marketed in Japan.
- Miyarisan Pharmaceut is TAHO’s Japanese licensing partner, according to the company.